Whitepaper: The Rise of Bigger, Earlier M&A Deals for Biotech

Continuing a trend that began in 2017, this year has seen the rise of big investment deals in the biotech sector.  Smaller biotechs are also cashing in as Big Pharma look to fill dwindling pipelines; according to Bloomberg data, biotech acquisitions are expected to be at the highest level for 12 years. Analysing this data from … Continue reading Whitepaper: The Rise of Bigger, Earlier M&A Deals for Biotech

Read more